APOL1Risk Variants Predict Histopathology and Progression to ESRD in HIV-Related Kidney Disease

作者: Derek M. Fine , Walter G. Wasser , Michelle M. Estrella , Mohamed G. Atta , Michael Kuperman

DOI: 10.1681/ASN.2011060562

关键词:

摘要: With earlier institution of antiretroviral therapy, kidney diseases other than HIV-associated nephropathy (HIVAN) predominate in HIV-infected persons. Outcomes for these are typically worse among those infected with HIV, but the reasons this not clear. Here, we examined role APOL1 risk variants predicting renal histopathology and progression to ESRD 98 African Americans non-HIVAN disease on biopsy. We used survival analysis determine time associated genotype. Among 29 patients two alleles, majority (76%) had FSGS 10% hypertensive nephrosclerosis. In contrast, 54 one allele, 47% immune-complex GN as predominant lesion only 23% FSGS. 25 no 40% 12% 310 person-years observation, progressed ESRD. adjusted analyses, individuals alleles a nearly three-fold higher compared or zero (P=0.03). summary, data demonstrate an association between outcomes disease, suggesting possible use genotyping help guide care patients.

参考文章(42)
Anton J.G. Horrevoets, Ruud D. Fontijn, Anton Jan van Zonneveld, Carlie J.M. de Vries, Jan Wouter ten Cate, Hans Pannekoek, Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes. Blood. ,vol. 93, pp. 3418- 3431 ,(1999) , 10.1182/BLOOD.V93.10.3418.410K23_3418_3431
Sayed Tabatabai, C. John Sperati, Mohamed G. Atta, Kashif Janjua, Christopher Roxbury, Gregory M. Lucas, Derek M. Fine, Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection. Clinical Journal of The American Society of Nephrology. ,vol. 4, pp. 1766- 1773 ,(2009) , 10.2215/CJN.03880609
Elizabeth George, Gregory M Lucas, Girish N Nadkarni, Derek M Fine, Richard Moore, Mohamed G Atta, Kidney Function and the Risk of Cardiovascular Events in HIV-1 Infected Patients AIDS. ,vol. 24, pp. 387- 394 ,(2010) , 10.1097/QAD.0B013E3283359253
Christina M. Wyatt, Susan Morgello, Rebecca Katz-Malamed, Catherine Wei, Mary E. Klotman, Paul E. Klotman, Vivette D. D'Agati, The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy Kidney International. ,vol. 75, pp. 428- 434 ,(2009) , 10.1038/KI.2008.604
Siqin Zhaorigetu, Guanghua Wan, Ramesh Kaini, Guanghua Wan, Zeyu Jiang, Chien-an A. Hu, ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death Autophagy. ,vol. 4, pp. 1079- 1082 ,(2008) , 10.4161/AUTO.7066
Andy Choi, Rebecca Scherzer, Peter Bacchetti, Phyllis C. Tien, Michael S. Saag, Cynthia L. Gibert, Lynda A. Szczech, Carl Grunfeld, Michael G. Shlipak, Cystatin C, Albuminuria, and 5-Year All-Cause Mortality in HIV-Infected Persons American Journal of Kidney Diseases. ,vol. 56, pp. 872- 882 ,(2010) , 10.1053/J.AJKD.2010.05.019
Nigel M. Page, David J. Butlin, Khomsorn Lomthaisong, Philip J. Lowry, The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics. ,vol. 74, pp. 71- 78 ,(2001) , 10.1006/GENO.2001.6534
Katherine Samaras, Prevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral Therapy Journal of Acquired Immune Deficiency Syndromes. ,vol. 50, pp. 499- 505 ,(2009) , 10.1097/QAI.0B013E31819C291B
Philippe N. Duchateau, Clive R. Pullinger, Roberto E. Orellana, Steven T. Kunitake, Josefina Naya-Vigne, Patricia M. O’Connor, Mary J. Malloy, John P. Kane, Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas IDENTIFICATION, CLONING, CHARACTERIZATION, AND PLASMA DISTRIBUTION OF APOLIPOPROTEIN L Journal of Biological Chemistry. ,vol. 272, pp. 25576- 25582 ,(1997) , 10.1074/JBC.272.41.25576